関連する実験動画
Updated: Sep 10, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
348
2型糖尿病における縦断的な体重動態:総合的なケアプログラムからの洞察
Ana C García-Ulloa1, Liliana Pérez-Peralta2, Luz E Urbina-Arronte1
1Centro de Atención Integral del Paciente con Diabetes, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Archives of medical research
|August 20, 2025
まとめ
2型糖尿病 (T2D) の多分野介入では,患者の35. 5%が減量したが,正常な体重は3年後に16. 6%しか達成されなかった. 体重変化の予測要因を特定することは 標的型糖尿病治療の鍵です
科学分野:
- 内分泌学
- 代謝 健康
- 糖尿病 管理
背景:
- 2型糖尿病 (T2D) と関連する健康問題には 重量や肥満が主な原因です
- 適度な体重減少は,代謝制御を改善し,T2D患者の心血管疾患のリスクを軽減することが知られている.
研究 の 目的:
- 多分野介入の後に体重の変化を経験した2型糖尿病患者の人口統計学的および臨床的特徴を特定する.
- この患者集団における体重増加,維持,減量の予測要因を理解するためです
主な方法:
- T2Dの622人の患者の分析と3年間の追跡データ.
- 診断から5年未満で,障害となる慢性的な合併症はない.
- 統計的分析には,記述的統計,ANOVA/Kruskal-Wallisテスト,および予測因子の識別のためのロジスティック回帰が含まれていた.
主要な成果:
- 3年目には35. 5%が減量し,33. 9%が体重を維持し,30. 5%が体重増加し,16. 6%が正常体重に達した.
- 若い患者は体重が増える傾向がありました.
- 3ヶ月後に予想された体重増加は,HbA1cの上昇と生活の質の低下によるものです.
- ベースラインより高いBMI,より長い糖尿病の持続時間,およびiSGLT2治療は体重減少を予測しました.
結論:
- 多分野介入を受けたT2D患者の有意な割合は3年後には正常な体重に達しなかった.
- 体重変化の予測要因 (体重増加対減量) が特定され,パーソナライズされた介入のための潜在的なターゲットが強調されました.
- T2Dのケアにおける体重管理を最適化するために,適した戦略に関するさらなる研究が必要である.
関連する概念動画
Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K

